Search
Menu
All issues Volume 8 (2020) Regen Med Res, 8 (2020) 3 References
Open Access
Issue
Regen Med Res
Volume 8, 2020
Article Number 3
Number of page(s) 7
DOI https://doi.org/10.1051/rmr/200002
Published online 03 December 2020
  1. Bray CC, Walker CM, Spence DD (2017) Orthobiologics in pediatric sports medicine. Orthop Clin North Am 48, 333‒342. [CrossRef] [PubMed] [Google Scholar]
  2. Southworth TM, Naveen NB, Nwachukwu BU, Cole BJ, Frank RM (2019) Orthobiologics for focal articular cartilage defects. Clin Sports Med 38, 109‒122. [CrossRef] [PubMed] [Google Scholar]
  3. Andia I, Maffulli N (2013) Platelet-rich plasma for managing pain and inflammation in osteoarthritis. Nat Rev Rheumatol 9, 721‒730. [CrossRef] [PubMed] [Google Scholar]
  4. Alsousou J, Thompson M, Hulley P, Noble A, Willett K (2009) The biology of platelet-rich plasma and its application in trauma and orthopaedic surgery: a review of the literature. J Bone Joint Surg Br 91, 987‒996. [CrossRef] [PubMed] [Google Scholar]
  5. Campbell KA, Saltzman BM, Mascarenhas R, Khair MM, Verma NN, Bach BR, Cole BJ (2015) Does intra-articular platelet-rich plasma injection provide clinically superior outcomes compared with other therapies in the treatment of knee osteoarthritis? A systematic review of overlapping meta-analyses. Arthroscopy 31, 2213‒2221. [CrossRef] [PubMed] [Google Scholar]
  6. Foster TE, Puskas BL, Mandelbaum BR, Gerhardt MB, Rodeo SA (2009) Platelet-rich plasma: from basic science to clinical applications. Am J Sports Med 37, 2259‒2272. [CrossRef] [Google Scholar]
  7. Cerza F, Carnì S, Carcangiu A, Di Vavo I, Schiavilla V, Pecora A, De Biasi G, Ciuffreda M (2012) Comparison between hyaluronic acid and platelet-rich plasma, intra-articular infiltration in the treatment of gonarthrosis. Am J Sports Med 40, 2822‒2827. [CrossRef] [PubMed] [Google Scholar]
  8. Patel S, Dhillon MS, Aggarwal S, Marwaha N, Jain A (2013) Treatment with platelet-rich plasma is more effective than placebo for knee osteoarthritis: a prospective, double-blind, randomized trial. Am J Sports Med 41, 356‒364. [CrossRef] [PubMed] [Google Scholar]
  9. Simental-Mendía M, Vílchez-Cavazos JF, Peña-Martínez VM, Said-Fernández S, Lara-Arias J, Martínez-Rodríguez HG (2016) Leukocyte-poor platelet-rich plasma is more effective than the conventional therapy with acetaminophen for the treatment of early knee osteoarthritis. Arch Orthop Trauma Surg 136, 1723‒1732. [CrossRef] [Google Scholar]
  10. Smith PA (2016) Intra-articular autologous conditioned plasma injections provide safe and efficacious treatment for knee osteoarthritis: an FDA-sanctioned, randomized, double-blind, placebo-controlled clinical trial. Am J Sports Med 44, 884‒891. [CrossRef] [Google Scholar]
  11. DeLong JM, Russell RP, Mazzocca AD (2012) Platelet-rich plasma: the PAW classification system. Arthroscopy 28, 998‒1009. [CrossRef] [PubMed] [Google Scholar]
  12. Dohan Ehrenfest DM, Andia I, Zumstein MA, Zhang CQ, Pinto NR, Bielecki T (2014) Classification of platelet concentrates (Platelet-Rich Plasma-PRP, Platelet-Rich Fibrin-PRF) for topical and infiltrative use in orthopedic and sports medicine: current consensus, clinical implications and perspectives. Muscles Ligaments Tendons J, 4, 3‒9. [CrossRef] [PubMed] [Google Scholar]
  13. Kobayashi Y, Saita Y, Nishio H, Ikeda H, Takazawa Y, Nagao M, Takaku T, Komatsu N, Kaneko K (2016) Leukocyte concentration and composition in platelet-rich plasma (PRP) influences the growth factor and protease concentrations. J Orthop Sci 21, 683‒689. [CrossRef] [PubMed] [Google Scholar]
  14. Riboh JC, Yanke AB, Cole BJ (2016) Effect of leukocyte concentration on the efficacy of PRP in the treatment of knee OA: response. Am J Sports Med 44, NP66‒NP67. [CrossRef] [Google Scholar]
  15. O'Shaughnessey KM, Panitch A, Woodell-May JE (2011) Blood-derived anti-inflammatory protein solution blocks the effect of IL-1 beta on human macrophages in vitro. Inflamm Res 60, 929‒936. [CrossRef] [Google Scholar]
  16. Pifer MA, Maerz T, Baker KC, Anderson K (2014) Matrix metalloproteinase content and activity in low-platelet, low-leukocyte and high-platelet, high-leukocyte platelet rich plasma (PRP) and the biologic response to PRP by human ligament fibroblasts. Am J Sports Med 42, 1211‒1218. [CrossRef] [Google Scholar]
  17. Oudelaar BW, Peerbooms JC, Huis In't Veld R, Vochteloo AJH (2019) Concentrations of blood components in commercial platelet-rich plasma separation systems: a review of the literature. Am J Sports Med 47, 479‒487. [CrossRef] [Google Scholar]
  18. Woodell-May J, Matuska A, Oyster M, Welch Z, O'Shaughnessey K, Hoeppner J (2011) Autologous protein solution inhibits MMP-13 production by IL-1 beta and TNF alpha-stimulated human articular chondrocytes. J Orthop Res 29, 1320‒1326. [CrossRef] [PubMed] [Google Scholar]
  19. O'Shaughnessey K, Matuska A, Hoeppner J, Farr J, Klaassen M, Kaeding C, Lattermann C, King W, Woodell-May J (2014) Autologous protein solution prepared from the blood of osteoarthritic patients contains an enhanced profile of anti-inflammatory cytokines and anabolic growth factors. J Orthop Res 32, 1349‒1355. [CrossRef] [PubMed] [Google Scholar]
  20. Kon E, Engebretsen L, Verdonk P, Nehrer S, Filardo G (2018) Clinical outcomes of knee osteoarthritis treated with an autologous protein solution injection: a 1-year pilot double-blinded randomized controlled trial. Am J Sports Med 46, 171‒180. [CrossRef] [Google Scholar]